TUBAP13

Across TCGA pan-cancer cohorts, TUBAP13 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated TUBAP13 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TUBAP13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TUBAP13 expression acts as an unfavorable survival marker, although some lineages such as MESO and LGG show a favorable association.

KIRP, DLBC, and MESO are the cancer types where TUBAP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.739	0.891	<.001	83	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	63	view →
MESO	OS	Median	All	0.493	0.279	.001	49	view →
STAD	OS	Quartile	All	0.232	0.498	.004	46	view →
LIHC	OS	Tertile	All	0.651	0.820	<.001	46	view →
LGG	DFS	Median	All	0.881	0.783	<.001	39	view →
LUSC	OS	Quartile	All	0.837	0.684	<.001	26	view →
PAAD	DFS	Tertile	II,III,IV	0.329	0.488	.004	18	view →
ACC	DFS	Quartile	All	0.258	0.657	.010	8	view →
GBM	DFS	Quartile	All	0.528	0.252	.011	6	view →
ESCA	DFS	Quartile	All	0.345	0.566	.021	6	view →
COAD	OS	Quartile	IV	1.000	0.501	.017	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

TUBAP13–KIRP (DFS)

Open the KIRP breakdown →